• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[精神药物试验的规划。统计评估。假设与方法]

[Planning of psychotropic drug trials. Statistical evaluation. Hypotheses and methods].

作者信息

Immich H

出版信息

Pharmakopsychiatr Neuropsychopharmakol. 1977 May;10(3):185-92. doi: 10.1055/s-0028-1094539.

DOI:10.1055/s-0028-1094539
PMID:30098
Abstract

Any reasonable evaluation presupposes a precise question. Furthermore it is necessary to eliminate all factors of disturbance, which are able either to simulate or to mask a result of evaluation. The most important of these factors is the psychiatrist himself. Therefore, experimental designs have to taken in account the factor psychiatrist. Criteria of the effects of any drug must be relevant with regard to comparison of two or more drug effects. The reproduciability of criteria is very desirable, but a wish-fulfilment under the most circumstances. Because criteria should be independent and mutually exclusive, all scales like the Hamiltons one are not suitable for evaluation. Finally one should use as few criteria as possible. Models of evaluation are described for the most frequent questions in connection with clinical trials in psychopharmacology.

摘要

任何合理的评估都预先假定有一个精确的问题。此外,有必要消除所有干扰因素,这些因素要么能够模拟要么掩盖评估结果。其中最重要的因素就是精神科医生本人。因此,实验设计必须考虑到精神科医生这一因素。任何药物效果的标准必须与两种或更多药物效果的比较相关。标准的可重复性是非常可取的,但在大多数情况下只是一种愿望。由于标准应该是独立且相互排斥的,所有像汉密尔顿量表这样的量表都不适合用于评估。最后,应该尽可能少地使用标准。针对精神药理学临床试验中最常见的问题描述了评估模型。

相似文献

1
[Planning of psychotropic drug trials. Statistical evaluation. Hypotheses and methods].[精神药物试验的规划。统计评估。假设与方法]
Pharmakopsychiatr Neuropsychopharmakol. 1977 May;10(3):185-92. doi: 10.1055/s-0028-1094539.
2
[Difficulties of a clinician in planning psychopharmacological trials (author's transl)].临床医生在规划精神药理学试验中的困难(作者译)
Pharmakopsychiatr Neuropsychopharmakol. 1977 May;10(3):140-6. doi: 10.1055/s-0028-1094531.
3
[Rater-specific interference factors in clinical trials (author's transl)].临床试验中特定评估者的干扰因素(作者译)
Pharmakopsychiatr Neuropsychopharmakol. 1977 May;10(3):152-62. doi: 10.1055/s-0028-1094534.
4
Time-blind evaluation of psychopathology in drug research.药物研究中精神病理学的时间盲法评估。
Acta Psychiatr Belg. 1978 Jul-Aug;78(4):635-45.
5
[Statistical aspects in planning psychotropic drug trials (author's transl)].
Pharmakopsychiatr Neuropsychopharmakol. 1977 May;10(3):132-9. doi: 10.1055/s-0028-1094530.
6
The AMDP-system in clinical psychopharmacology.临床精神药理学中的AMDP系统。
Pharmacopsychiatry. 1986 Mar;19(2):55-7. doi: 10.1055/s-2007-1017153.
7
[Taxonomy and assessment of psychological investigation methods in psychotropic drug trials (author's transl)].
Pharmakopsychiatr Neuropsychopharmakol. 1977 May;10(3):165-75. doi: 10.1055/s-0028-1094536.
8
[Clinical trials in psychiatry. Recent evolution of the methodology in France (author's transl)].
Nouv Presse Med. 1979 Feb 24;8(9):677-82.
9
Rating scales in psychopharmacology. Statistical aspects.精神药理学中的评定量表。统计学方面。
Acta Psychiatr Belg. 1988 Jul-Aug;88(4):291-302.
10
[Planning of psychotropic drug trials. Control of interfering factors].
Pharmakopsychiatr Neuropsychopharmakol. 1977 May;10(3):149-51. doi: 10.1055/s-0028-1094533.